Dr. Luckenbaugh looks back on testicular cancer/germ cell tumor research from ASCO 2022
Amy N. Luckenbaugh, MD, recaps 5 presentations from the 2022 American Society of Clinical Oncology Annual Meeting.
In this video, Amy N. Luckenbaugh, MD, gives a recap of noteworthy testicular cancer/germ cell tumor abstracts presented at the 2022 American Society of Clinical Oncology Annual Meeting. Luckenbaugh is an assistant professor of urology at Vanderbilt University Medical Center, Nashville, Tennessee.
The following 5 abstracts are summarized:
Abstract 5007 (Truong et al): Defining germline genetics of germ cell tumor: Implications for genetic testing and clinical management
Abstract 5008 (Tandstad et al): Late relapses in testicular cancer: Results from a national cohort
Abstract 5032 (Taza et al): Late relapses in testicular cancer: Results from a national cohort
Abstract 5033 (Zheng et al): Epigenetic age acceleration in U.S. testicular cancer survivors (TCS)
Abstract 5034 (King et al): Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT)
